Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 97-109

  Stolp, Jessica ^a,b   Mariño, Eliana ^a,b   Batten, Marcel ^a,b   Sierro, Frederic ^a,b   Cox, Selwyn L ^a,b   Grey, Shane T ^a,b   Silveira, Pablo A ^a,b,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOE GENE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BID GENE; BONE MARROW; CCBP2 GENE; CD55 GENE; CHIMERA; CONTROLLED STUDY; CXCR7 GENE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; INSULIN DEPENDENT DIABETES MELLITUS; LGALS1 GENE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PLA2G7 GENE; PRE B LYMPHOCYTE; PRF1 GENE; PRIORITY JOURNAL; PROTEIN FAMILY; RGS13 GENE; S1PR3 GENE; SPLEEN; SPN GENE; T LYMPHOCYTE; TLR3 GENE;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; MICE, TRANSGENIC; PROPROTEIN CONVERTASES; RECEPTOR, NOTCH2; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, LYSOSPHINGOLIPID; SERINE ENDOPEPTIDASES; SPLEEN;

EID: 84879617833     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203252     Document Type: Article

References (62)

1. Monroe, J. G., and K. Dorshkind. 2007. Fate decisions regulating bone marrow and peripheral B lymphocyte development. Adv. Immunol. 95: 1-50. (Pubitemid 47380502)
2. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196. (Pubitemid 40563168)
3. Attanavanich, K., and J. F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172: 803-811. (Pubitemid 38113736)
4. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62. (Pubitemid 350286204)
5. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20: 149-157.
6. Wither, J. E., V. Roy, and L. A. Brennan. 2000. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB 3 NZW)F(1) mice. Clin. Immunol. 94: 51-63. (Pubitemid 30026911)
7. Mandik-Nayak, L., S. J. Seo, C. Sokol, K. M. Potts, A. Bui, and J. Erikson. 1999. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189: 1799-1814. (Pubitemid 29272697)
8. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192: 1453-1466.
9. Viau, M., and M. Zouali. 2005. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 114: 17-26. (Pubitemid 39642786)
10. Groom, J., S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock, P. Schneider, J. Tschopp, T. G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109: 59-68. (Pubitemid 34052542)
11. Segundo, C., C. Rodríguez, A. García-Poley, M. Aguilar, I. Gavilán, C. Bellas, and J. A. Brieva. 2001. Thyroid-infiltrating B lymphocytes in Graves' disease are related to marginal zone and memory B cell compartments. Thyroid 11: 525-530.
12. Mariño, E., M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey. 2008. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57: 395-404.
13. Quinn, W. J., III, N. Noorchashm, J. E. Crowley, A. J. Reed, H. Noorchashm, A. Naji, and M. P. Cancro. 2006. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol. 176: 7159-7164. (Pubitemid 43849016)
14. Acevedo-Suárez, C. A., C. Hulbert, E. J. Woodward, and J. W. Thomas. 2005. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes. J. Immunol. 174: 827-833.
15. Noorchashm, H., D. J. Moore, Y. K. Lieu, N. Noorchashm, A. Schlachterman, H. K. Song, C. F. Barker, and A. Naji. 1999. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell. Immunol. 195: 75-79. (Pubitemid 29384265)
16. Nguyen, C. Q., H. Kim, J. G. Cornelius, and A. B. Peck. 2007. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6. NOD-Aec1Aec2 mice is dependent on complement component-3. J. Immunol. 179: 2318-2329.
17. Silveira, P. A., E. Johnson, H. D. Chapman, T. Bui, R. M. Tisch, and D. V. Serreze. 2002. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32: 3657-3666. (Pubitemid 36024402)
18. Wicker, L. S., M. C. Appel, F. Dotta, A. Pressey, B. J. Miller, N. H. DeLarato, P. A. Fischer, R. C. Boltz, Jr., and L. B. Peterson. 1992. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 176: 67-77.
19. Gorelik, L., K. Gilbride, M. Dobles, S. L. Kalled, D. Zandman, and M. L. Scott. 2003. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198: 937-945. (Pubitemid 37152930)
20. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710. (Pubitemid 30002351)
21. Rolf, J., V. Motta, N. Duarte, M. Lundholm, E. Berntman, M. L. Bergman, L. Sorokin, S. L. Cardell, and D. Holmberg. 2005. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821-4827.
22. Silveira, P. A., J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172: 5086-5094. (Pubitemid 38456437)
23. Bao, M., Y. Yang, H. S. Jun, and J. W. Yoon. 2002. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 168: 5369-5375. (Pubitemid 34496006)
24. Makino, S., K. Kunimoto, Y. Muraoka, and K. Katagiri. 1981. Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu 30: 137-140.
25. Srivastava, B., W. J. Quinn, III, K. Hazard, J. Erikson, and D. Allman. 2005. Characterization of marginal zone B cell precursors. J. Exp. Med. 202: 1225-1234. (Pubitemid 41586953)
26. Zekavat, G., R. Mozaffari, V. J. Arias, S. Y. Rostami, A. Badkerhanian, A. J. Tenner, K. E. Nichols, A. Naji, and H. Noorchashm. 2010. A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state. Immunogenetics 62: 397-407.
27. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962. (Pubitemid 44894955)
28. Cox, S. L., J. Stolp, N. L. Hallahan, J. Counotte, W. Zhang, D. V. Serreze, A. Basten, and P. A. Silveira. 2010. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a b-cell neo-self-antigen in type 1 diabetes prone NOD mice. Eur. J. Immunol. 40: 3413-3425.
29. Panigrahi, A. K., N. G. Goodman, R. A. Eisenberg, M. R. Rickels, A. Naji, and E. T. Luning Prak. 2008. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J. Exp. Med. 205: 2985-2994.
30. Bonifacio, E., M. Atkinson, G. Eisenbarth, D. Serreze, T. W. Kay, E. Lee-Chan, and B. Singh. 2001. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50: 2451-2458.
31. Baxter, A. G., and T. E. Mandel. 1991. Hemolytic anemia in non-obese diabetic mice. Eur. J. Immunol. 21: 2051-2055.
32. Baxter, A. G., A. C. Horsfall, D. Healey, P. Ozegbe, S. Day, D. G. Williams, and A. Cooke. 1994. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83: 227-231. (Pubitemid 24315591)
33. Carrillo, J., M. C. Puertas, A. Alba, R. M. Ampudia, X. Pastor, R. Planas, N. Riutort, N. Alonso, R. Pujol-Borrell, P. Santamaria, et al. 2005. Islet-infiltrating B-cells in nonobese diabetic mice predominantly target nervous system elements. Diabetes 54: 69-77. (Pubitemid 40105096)
34. Chen, X., F. Martin, K. A. Forbush, R. M. Perlmutter, and J. F. Kearney. 1997. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9: 27-41. (Pubitemid 27062886)
35. Wellmann, U., A. Werner, and T. H. Winkler. 2001. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol. 31: 2800-2810. (Pubitemid 32898748)
36. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in nonautoimmune mice. Nature 349: 331-334. (Pubitemid 21912076)
37. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
38. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9: 767-777.
39. Su, T. T., B. Guo, B. Wei, J. Braun, and D. J. Rawlings. 2004. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197: 161-178. (Pubitemid 38142175)
40. Mackay, F., P. A. Silveira, and R. Brink. 2007. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 19: 327-336. (Pubitemid 46687013)
41. Cariappa, A., H. C. Liou, B. H. Horwitz, and S. Pillai. 2000. Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192: 1175-1182.
42. Sasaki, Y., E. Derudder, E. Hobeika, R. Pelanda, M. Reth, K. Rajewsky, and M. Schmidt-Supprian. 2006. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24: 729-739. (Pubitemid 43867365)
43. Kaufman, C. L., H. Li, and S. T. Ildstad. 1997. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J. Immunol. 158: 2435-2442. (Pubitemid 127470031)
44. Kim, Y. M., J. Y. Pan, G. A. Korbel, V. Peperzak, M. Boes, and H. L. Ploegh. 2006. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc. Natl. Acad. Sci. USA 103: 3327-3332. (Pubitemid 43346469)
45. Tan, J. B., K. Xu, K. Cretegny, I. Visan, J. S. Yuan, S. E. Egan, and C. J. Guidos. 2009. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity 30: 254-263.
46. Cinamon, G., M. Matloubian, M. J. Lesneski, Y. Xu, C. Low, T. Lu, R. L. Proia, and J. G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5: 713-720. (Pubitemid 39023303)
47. Wang, H., N. Beaty, S. Chen, C. F. Qi, M. Masiuk, D. M. Shin, and H. C. Morse, III. 2012. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 119: 465-468.
48. Sierro, F., C. Biben, L. Martínez-Muñoz, M. Mellado, R. M. Ransohoff, M. Li, B. Woehl, H. Leung, J. Groom, M. Batten, et al. 2007. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104: 14759-14764. (Pubitemid 350003216)
49. Naumann, U., E. Cameroni, M. Pruenster, H. Mahabaleshwar, E. Raz, H. G. Zerwes, A. Rot, and M. Thelen. 2010. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5: e9175.
50. You, Y., H. Zhao, Y. Wang, and R. H. Carter. 2009. Cutting edge: primary and secondary effects of CD19 deficiency on cells of the marginal zone. J. Immunol. 182: 7343-7347.
51. Anzelon, A. N., H. Wu, and R. C. Rickert. 2003. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4: 287-294. (Pubitemid 36322140)
52. Qian, Y., H. Wang, and S. H. Clarke. 2004. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J. Immunol. 172: 625-635. (Pubitemid 38020521)
53. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188. (Pubitemid 34461262)
54. Fletcher, C. A., A. P. Sutherland, J. R. Groom, M. L. Batten, L. G. Ng, J. Gommerman, and F. Mackay. 2006. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur. J. Immunol. 36: 2504-2514. (Pubitemid 44420606)
55. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999. (Pubitemid 30243593)
56. Chang, N. H., Y. H. Cheung, C. Loh, E. Pau, V. Roy, Y. C. Cai, and J. Wither. 2010. B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One 5: e11691.
57. Sundström, M., and K. Lejon. 2007. Idd-linked genetic regulation of TACIhigh expressing B cells in NOD mice. J. Autoimmun. 29: 116-124.
58. Fra, A. M., M. Locati, K. Otero, M. Sironi, P. Signorelli, M. L. Massardi, M. Gobbi, A. Vecchi, S. Sozzani, and A. Mantovani. 2003. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170: 2279-2282. (Pubitemid 36245612)
59. Hansell, C. A., C. Schiering, R. Kinstrie, L. Ford, Y. Bordon, I. B. McInnes, C. S. Goodyear, and R. J. Nibbs. 2011. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117: 5413-5424.
60. Shi, G. X., K. Harrison, G. L. Wilson, C. Moratz, and J. H. Kehrl. 2002. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169: 2507-2515. (Pubitemid 34920995)
61. Fabris, M., F. Grimaldi, D. Villalta, A. Picierno, C. Fabro, M. Bolzan, S. De Vita, and E. Tonutti. 2010. BLyS and April serum levels in patients with autoimmune thyroid diseases. Autoimmun. Rev. 9: 165-169.
62. Bergholdt, R., C. Brorsson, A. Palleja, L. A. Berchtold, T. Fløyel, C. H. Bang-Berthelsen, K. S. Frederiksen, L. J. Jensen, J. Størling, and F. Pociot. 2012. Identification of novel type 1 diabetes candidate genes by integrating genomewide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61: 954-962.